Regulon

Regulon: R-140

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
171.7579810Pr-95Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3459 ENSG00000027697 IFNGR1 A0A2R8Y4U4
3430 ENSG00000068079 IFI35 P80217
5720 ENSG00000092010 PSME1 Q06323
5721 ENSG00000100911 PSME2 H0YLG1
969 ENSG00000110848 CD69 Q07108
9450 ENSG00000112799 LY86 O95711
9111 ENSG00000123609 NMI Q13287
6737 ENSG00000132109 TRIM21 P19474
5920 ENSG00000133321 RARRES3 Q9UL19
834 ENSG00000137752 CASP1 P29466
9446 ENSG00000148834 GSTO1 P78417
6001 ENSG00000148908 RGS10 O43665
10791 ENSG00000168899 VAMP5 Q6FG93
1043 ENSG00000169442 CD52 V9HWN9
2745 ENSG00000173221 GLRX P35754
5699 ENSG00000205220 PSMB10 P40306
567 ENSG00000273686 B2M J3KNU0

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
OPROZOMIBPSMD1Small moleculeINHIBITOR26S proteosome inhibitor10
INTERFERON GAMMA-1BIFNGR1ProteinAGONISTInterferon gamma receptor agonist40
IXAZOMIBPSMD1Small moleculeINHIBITOR26S proteasome inhibitor40
MARIZOMIBPSMB2Small moleculeINHIBITOR20S proteosome inhibitor33
NIVOCASANCASP1Small moleculeINHIBITORCaspase-9 inhibitor20
BORTEZOMIBPSMD1Small moleculeINHIBITOR26S proteosome inhibitor41
EMRICASANCASP4Small moleculeINHIBITORCaspase inhibitor20
BELNACASANCASP1Small moleculeINHIBITORCaspase-1 inhibitor20
IXAZOMIB CITRATEPSMD1Small moleculeINHIBITOR26S proteosome inhibitor40
ALEMTUZUMABCD52AntibodyINHIBITORCAMPATH-1 antigen inhibitor40
CARFILZOMIBPSMD1ProteinINHIBITOR26S proteosome inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-140

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs